The briefing
Clinical Lab Products highlights the ProVue Lung blood-based laboratory-developed test, which demonstrated high sensitivity for detecting lung cancer in high-risk individuals. The findings suggest potential for earlier detection pending further validation and clinical adoption.
Original headline
Blood Test Shows High Sensitivity for Early-Stage Lung Cancer Detection